Researchers are excited about the medication , a novel dual agonist showing remarkable outcomes in clinical trials for body reduction . It functions by impacting both systems: GLP-1 and GIP, which , https://sabrinajihb938596.bligblogging.com/41469609/this-new-possibility-for-weight-reduction